Moody Lynn & Lieberson, LLC Abb Vie Inc. Transaction History
Moody Lynn & Lieberson, LLC
- $1.54 Billion
- Q4 2024
A detailed history of Moody Lynn & Lieberson, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 155,952 shares of ABBV stock, worth $31.7 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
155,952
Previous 181,165
13.92%
Holding current value
$31.7 Million
Previous $35.8 Million
22.54%
% of portfolio
1.8%
Previous 2.32%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
4,097Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.2 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.06 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $359B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...